(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(Z,2S)-7-hydroxy-6-methyl-2-[(3S,5R,6S,8R,9S,10R,12R,13S,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol

C36H62O10 — CID 162934444

IUPAC(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(Z,2S)-7-hydroxy-6-methyl-2-[(3S,5R,6S,8R,9S,10R,12R,13S,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol
SMILESC/C(=C/CC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@H]1[C@H](O)C[C@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O)C[C@]12C)CO
InChIInChI=1S/C36H62O10/c1-19(17-37)9-8-12-36(7,46-31-29(44)28(43)27(42)23(18-38)45-31)20-10-14-34(5)26(20)21(39)15-24-33(4)13-11-25(41)32(2,3)30(33)22(40)16-35(24,34)6/h9,20-31,37-44H,8,10-18H2,1-7H3/b19-9-/t20-,21+,22-,23+,24-,25-,26+,27+,28-,29+,30-,31-,33+,34+,35+,36-/m0/s1
InChIKeySSPJYWUVFLPKSH-MPESEUKASA-N
MW654.88 g/mol
LogP2.27
Rot. Bonds8

About (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(Z,2S)-7-hydroxy-6-methyl-2-[(3S,5R,6S,8R,9S,10R,12R,13S,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol

(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(Z,2S)-7-hydroxy-6-methyl-2-[(3S,5R,6S,8R,9S,10R,12R,13S,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol (PubChem CID 162934444) has the molecular formula C36H62O10 and a molecular weight of 654.88 g/mol. Its IUPAC name is (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(Z,2S)-7-hydroxy-6-methyl-2-[(3S,5R,6S,8R,9S,10R,12R,13S,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol.

Molecular Properties

Compound Name(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(Z,2S)-7-hydroxy-6-methyl-2-[(3S,5R,6S,8R,9S,10R,12R,13S,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol
PubChem CID162934444
Molecular FormulaC36H62O10
Molecular Weight654.88 g/mol
Exact Mass654.43
IUPAC Name(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(Z,2S)-7-hydroxy-6-methyl-2-[(3S,5R,6S,8R,9S,10R,12R,13S,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol
SMILESC/C(=C/CC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@H]1[C@H](O)C[C@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O)C[C@]12C)CO
InChIInChI=1S/C36H62O10/c1-19(17-37)9-8-12-36(7,46-31-29(44)28(43)27(42)23(18-38)45-31)20-10-14-34(5)26(20)21(39)15-24-33(4)13-11-25(41)32(2,3)30(33)22(40)16-35(24,34)6/h9,20-31,37-44H,8,10-18H2,1-7H3/b19-9-/t20-,21+,22-,23+,24-,25-,26+,27+,28-,29+,30-,31-,33+,34+,35+,36-/m0/s1
InChIKeySSPJYWUVFLPKSH-MPESEUKASA-N
XLogP2.27
TPSA180.30 Ų
H-Bond Donors8
H-Bond Acceptors10
Rotatable Bonds8
Heavy Atoms46
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500654.88
LogP ≤ 52.27
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(Z,2S)-7-hydroxy-6-methyl-2-[(3S,5R,6S,8R,9S,10R,12R,13S,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(Z,2S)-7-hydroxy-6-methyl-2-[(3S,5R,6S,8R,9S,10R,12R,13S,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol?
The IUPAC name of (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(Z,2S)-7-hydroxy-6-methyl-2-[(3S,5R,6S,8R,9S,10R,12R,13S,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol (CID 162934444) is (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(Z,2S)-7-hydroxy-6-methyl-2-[(3S,5R,6S,8R,9S,10R,12R,13S,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol.
What is the SMILES notation for (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(Z,2S)-7-hydroxy-6-methyl-2-[(3S,5R,6S,8R,9S,10R,12R,13S,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol?
The canonical SMILES for (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(Z,2S)-7-hydroxy-6-methyl-2-[(3S,5R,6S,8R,9S,10R,12R,13S,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol is C/C(=C/CC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@H]1[C@H](O)C[C@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O)C[C@]12C)CO.
What is the InChIKey of (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(Z,2S)-7-hydroxy-6-methyl-2-[(3S,5R,6S,8R,9S,10R,12R,13S,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol?
The InChIKey is SSPJYWUVFLPKSH-MPESEUKASA-N. The full InChI is InChI=1S/C36H62O10/c1-19(17-37)9-8-12-36(7,46-31-29(44)28(43)27(42)23(18-38)45-31)20-10-14-34(5)26(20)21(39)15-24-33(4)13-11-25(41)32(2,3)30(33)22(40)16-35(24,34)6/h9,20-31,37-44H,8,10-18H2,1-7H3/b19-9-/t20-,21+,22-,23+,24-,25-,26+,27+,28-,29+,30-,31-,33+,34+,35+,36-/m0/s1.
What are the key properties of (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(Z,2S)-7-hydroxy-6-methyl-2-[(3S,5R,6S,8R,9S,10R,12R,13S,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol?
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(Z,2S)-7-hydroxy-6-methyl-2-[(3S,5R,6S,8R,9S,10R,12R,13S,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol has a molecular weight of 654.88 g/mol, XLogP of 2.27, 8 rotatable bonds, 8 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(Z,2S)-7-hydroxy-6-methyl-2-[(3S,5R,6S,8R,9S,10R,12R,13S,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol is sourced from PubChem (CID 162934444), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).